| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 310.64 KB | Adobe PDF |
Orientador(es)
Resumo(s)
Introdução: Os inibidores da bomba de protões (IBPs) são utilizados no tratamento da patologia gastrointestinal e prevenção da hemorragia digestiva alta, frequentemente de forma inadequada nos doentes hospitalizados.
Métodos: Realizou-se um estudo transversal entre 15 de Marçoe 15 de Maio de 2015 para avaliar o padrão de prescrição de IBPs num Serviço de Medicina Interna, relativamente às indicações e aos custos.
Resultados: Foram incluídas 585 admissões, idade média de 75 anos. Dos casos, 163 já eram medicados com IBP pré-admissão, metade sem indicação. Dos episódios, 372 receberam um IBP na admissão/durante o internamento, mas apenas 63 casos tinham indicação para tal, pelo que 83% tinham sido medicados de forma inapropriada. Os predictores de prescrição inadequada de IBP foram o sexo feminino, idade ≥ 75 anos e
estar medicado com IBP pré-admissão. Conclusão: Custos totais, directamente relacionados aos IBPs, ascenderam aos €1079,96, em média €2,72 por episódio. A terapêutica com IBPs deve ser revista para reduzir prescrições inadequadas e custos.
Introduction: Proton pump inhibitors (PPIs) are used in the treatment of gastrointestinal pathology and prevention of upper gastrointestinal bleeding. They are frequently misused in hospitalized patients. Methods: We conducted an observational cross-sectional study between 15th March and 15th May 2015 to evaluate the prescription pattern of PPIs in an Internal Medicine ward regarding indications and costs. Results: Five hundred and eighty five admissions were includedwith an average age of 75 years. One hundred and sixtythree cases were medicated with a PPI prior to admission, half of them without indication. Three hundred seventy-two cases were prescribed a PPI on admission/during hospital stay but only 63 cases had a proper indication meaning that 83% were inadequately medicated. Predictors of inadequate PPI prescription were female sex, age ≥ 75 years and being medicated with a PPI prior to admission. Conclusion: Total cost s, directly related to PPIs were set at €1079.96, on average €2.72 per episode. Therapy with PPIs should be reviewed to decrease inadequate prescriptions and costs.
Introduction: Proton pump inhibitors (PPIs) are used in the treatment of gastrointestinal pathology and prevention of upper gastrointestinal bleeding. They are frequently misused in hospitalized patients. Methods: We conducted an observational cross-sectional study between 15th March and 15th May 2015 to evaluate the prescription pattern of PPIs in an Internal Medicine ward regarding indications and costs. Results: Five hundred and eighty five admissions were includedwith an average age of 75 years. One hundred and sixtythree cases were medicated with a PPI prior to admission, half of them without indication. Three hundred seventy-two cases were prescribed a PPI on admission/during hospital stay but only 63 cases had a proper indication meaning that 83% were inadequately medicated. Predictors of inadequate PPI prescription were female sex, age ≥ 75 years and being medicated with a PPI prior to admission. Conclusion: Total cost s, directly related to PPIs were set at €1079.96, on average €2.72 per episode. Therapy with PPIs should be reviewed to decrease inadequate prescriptions and costs.
Descrição
Palavras-chave
Hospital Departments Inibidores da Bomba de Protões de uso terapêutico Madeira Island Portugal Medicina Interna prescrição Inapropriada
Contexto Educativo
Citação
http://revista.spmi.pt
Editora
SPMI- Sociedade Portuguesa de Medicina Interna- http://revista.spmi.pt
